These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22503900)

  • 21. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual and opposing roles of ERK in regulating G(1) and S-G(2)/M delays in A549 cells caused by hyperoxia.
    Ko JC; Wang YT; Yang JL
    Exp Cell Res; 2004 Jul; 297(2):472-83. PubMed ID: 15212949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel blood test for the early detection of Alzheimer's disease.
    Rye PD; Booij BB; Grave G; Lindahl T; Kristiansen L; Andersen HM; Horndalsveen PO; Nygaard HA; Naik M; Hoprekstad D; Wetterberg P; Nilsson C; Aarsland D; Sharma P; Lönneborg A
    J Alzheimers Dis; 2011; 23(1):121-9. PubMed ID: 20930265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood-based neurochemical diagnosis of vascular dementia: a pilot study.
    Bibl M; Esselmann H; Mollenhauer B; Weniger G; Welge V; Liess M; Lewczuk P; Otto M; Schulz JB; Trenkwalder C; Kornhuber J; Wiltfang J
    J Neurochem; 2007 Oct; 103(2):467-74. PubMed ID: 17662050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.
    Simonsen AH; McGuire J; Podust VN; Davies H; Minthon L; Skoog I; Andreasen N; Wallin A; Waldemar G; Blennow K
    Neurobiol Aging; 2008 Jul; 29(7):961-8. PubMed ID: 17321007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
    Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
    Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A gene expression pattern in blood for the early detection of Alzheimer's disease.
    Booij BB; Lindahl T; Wetterberg P; Skaane NV; Sæbø S; Feten G; Rye PD; Kristiansen LI; Hagen N; Jensen M; Bårdsen K; Winblad B; Sharma P; Lönneborg A
    J Alzheimers Dis; 2011; 23(1):109-19. PubMed ID: 20930264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
    Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
    Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of 8-oxoguanine DNA glycosylase 1 (OGG1) and the level of p53 and TNF-αlpha proteins in peripheral lymphocytes of patients with Alzheimer's disease.
    Dezor M; Dorszewska J; Florczak J; Kempisty B; Jaroszewska-Kolecka J; Rozycka A; Polrolniczak A; Bugaj R; Jagodzinski PP; Kozubski W
    Folia Neuropathol; 2011; 49(2):123-31. PubMed ID: 21845541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sialic acid, homocysteine and CRP: potential markers for dementia.
    Davis G; Baboolal N; Nayak S; McRae A
    Neurosci Lett; 2009 Nov; 465(3):282-4. PubMed ID: 19766699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The measurement of phosphorylated tau in human cerebrospinal fluid as a diagnostic marker for Alzheimer's disease].
    Urakami K; Ito N; Arai H; Ishiguro K; Ohno H; Nakashima K
    Seishin Shinkeigaku Zasshi; 2003; 105(4):393-7. PubMed ID: 12806900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.
    Güntert A; Campbell J; Saleem M; O'Brien DP; Thompson AJ; Byers HL; Ward MA; Lovestone S
    J Alzheimers Dis; 2010; 21(2):585-96. PubMed ID: 20571216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers.
    Yoshida Y; Yoshikawa A; Kinumi T; Ogawa Y; Saito Y; Ohara K; Yamamoto H; Imai Y; Niki E
    Neurobiol Aging; 2009 Feb; 30(2):174-85. PubMed ID: 17688973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
    Watt AD; Perez KA; Faux NG; Pike KE; Rowe CC; Bourgeat P; Salvado O; Masters CL; Villemagne VL; Barnham KJ
    J Alzheimers Dis; 2011; 24(1):47-59. PubMed ID: 21157020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
    Zeng PY; Berger SL
    Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease.
    Bjerke M; Zetterberg H; Edman Å; Blennow K; Wallin A; Andreasson U
    J Alzheimers Dis; 2011; 27(3):665-76. PubMed ID: 21860087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
    Kapaki E; Paraskevas GP; Papageorgiou SG; Bonakis A; Kalfakis N; Zalonis I; Vassilopoulos D
    Alzheimer Dis Assoc Disord; 2008; 22(1):47-53. PubMed ID: 18317246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of Alzheimer's disease in body fluids.
    Zheng Y; He J; Hong T
    Sci China Life Sci; 2010 Apr; 53(4):490-6. PubMed ID: 20596916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No correlation between time-linked plasma and CSF Abeta levels.
    Le Bastard N; Aerts L; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Dec; 55(8):820-5. PubMed ID: 19695299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.